Cargando…

OR16-1 How Strong and Sustained Activation of the Estrogen Receptor-mediated Anticipatory Unfolded Protein Response Kills Breast and Ovarian Cancer Cells

In orthotopic xenografts and a PDX, our anticancer drug ErSO eradicates primary and metastatic therapy-resistant estrogen receptor alpha (ERα) positive breast cancer, and induces near-complete regression of ovarian cancer. The mechanism by which ErSO induces necrosis and kills ER positive cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boudreau, Matthew, Duraki, Darjan, Hergenrother, Paul, Kim, Ji Eun, Livezey, Mara, Nelson, Erik, Park, Ben H, Shapiro, David, Yang, Rachel, Ghosh, Santanu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629161/ http://dx.doi.org/10.1210/jendso/bvac150.1820

Ejemplares similares

ERa-Dependent Lethal Hyperactivation of the Anticipatory Unfolded Protein Response Induces Complete Regression Without Recurrence of Advanced Breast Cancer
por: Duraki, Darjan, et al.
Publicado: (2021)

OR16-06 A Novel Pathway Controlling Anticancer Drug Induced Immunogenic Necrosis In ERα Positive Cancer Cells
por: Zhu, Junyao, et al.
Publicado: (2023)

OR05-05 Lethal ERα-Dependent Hyperactivation of the Unfolded Protein Response Induces Complete Regression Without Recurrence of Primary and Metastatic Breast Cancer
por: Duraki, Darjan, et al.
Publicado: (2020)

A New Role for Estrogen Receptor α in Cell Proliferation and Cancer: Activating the Anticipatory Unfolded Protein Response
por: Livezey, Mara, et al.
Publicado: (2018)

Antiestrogen Resistant Cell Lines Expressing Estrogen Receptor α Mutations Upregulate the Unfolded Protein Response and are Killed by BHPI
por: Mao, Chengjian, et al.
Publicado: (2016)

Anticipatory Estrogen Activation of the Unfolded Protein Response is Linked to Cell Proliferation and Poor Survival in Estrogen Receptor α Positive Breast Cancer
por: Andruska, Neal, et al.
Publicado: (2014)

Targeting multidrug-resistant ovarian cancer through estrogen receptor α dependent ATP depletion caused by hyperactivation of the unfolded protein response
por: Zheng, Xiaobin, et al.
Publicado: (2016)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway
por: Iwabuchi, Erina, et al.
Publicado: (2021)

THU477 Drivers Of Estrogen Induced Invasive Lobular Carcinoma
por: Ufondu, Chinasa, et al.
Publicado: (2023)

OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
por: Hickey, Theresa E, et al.
Publicado: (2020)

OR05-01 Myeloid Cell Intrinsic NR0B2 Inhibits Regulatory T Cell Expansion Within The Tumor Microenvironment: Potential Novel Strategy For Breast Cancer Immunotherapy
por: Vidana Gamage, Hashni Epa, et al.
Publicado: (2023)

Prostate Cancer Stimulation by a Novel Liver X Receptor (LXRa)-Estrogen Related Receptor (ERRa) Axis
por: Song, Chung Seog, et al.
Publicado: (2021)

THU554 Unconventional Estrogen Receptor Antagonists Reveal Cryptic Therapeutic Anti-breast Cancer Transcriptional Pathways
por: Hancock, Govinda, et al.
Publicado: (2023)

SAT-331 Elucidating the Role of Breast Cancer Specific GATA3 Mutation in Estrogen Receptor Positive Breast Cancer
por: Lofgren, Kristopher, et al.
Publicado: (2019)

SAT-341 Pharmacology and Metabolism of GLL398 an Oral Selective Estrogen Receptor Degrader for Endocrine Therapy of Breast Cancer
por: Guo, Shanchun, et al.
Publicado: (2019)

SUN-134 Estrogen Induces Granulocytic Myeloid Derived Suppressor Cell Production to Potentially Modulate Lymphangioleiomyomatosis (LAM) Tumor Progression
por: Minor, Briaunna, et al.
Publicado: (2020)

Thyroid Hormone and Estrogen Promote Endocrine Resistance, Proliferation, Dedifferentiation, and Cancer Stem Cells in Steroid Receptor-Positive Breast Cancers
por: Wahdan-Alaswad, Reema S, et al.
Publicado: (2021)

Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
por: Yam, Andrew O., et al.
Publicado: (2023)

Salivary Estrogens Androgens and Aromatase Inhibitors by LC-MS/MS in Breast Cancer Patients Treated With Testosterone Pellets Combined With Aromatase Inhibitors
por: Zava, David T, et al.
Publicado: (2021)

THU486 Identification Of Metabolic And Molecular Mechanisms Driving Estrogen Receptor Positive Breast Cancer Disparities Using A Machine-Learning Pipeline
por: Casiano, Ashlie Santaliz, et al.
Publicado: (2023)

OR16-04 Androgen Deprivation Restricts Anti-tumor Immunity In Adrenocortical Carcinoma
por: Warde, Kate M, et al.
Publicado: (2023)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis
por: Etella, Abora, et al.
Publicado: (2023)

OR16-02 Histone ADP-Ribosylation Site Mutations As Oncogenic Drivers In Breast And Ovarian Cancers
por: Huang, Dan, et al.
Publicado: (2023)

SAT-338 Novel Preclinical Models of Estrogen Receptor Alpha Positive Metastatic Invasive Lobular Breast Carcinoma Using Dual Bioluminescent and Fluorescent Human Cell Line Xenografts
por: Tasdemir, Nilgun
Publicado: (2019)

OR16-01 A Common WNT4 Polymorphism Drives Gynecologic Cancer Phenotypes And Health Disparities
por: Bitler, Benjamin G, et al.
Publicado: (2023)

EMBR-16. SMOOTHENED-ACTIVATING LIPIDS DRIVE RESISTANCE TO CDK4/6 INHIBITION IN HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA
por: Daggubati, Vikas, et al.
Publicado: (2021)

OR16-03 Epigenetic Studies Of Pancreatic Neuroendocrine Tumours (PNETs) Reveal Decreased DNA Hydroxymethylation In Non-functioning PNETs But Not Insulinomas
por: English, Katherine A, et al.
Publicado: (2023)

Threat imminence reveals links among unfolding of anticipatory physiological response, cortical-subcortical intrinsic functional connectivity, and anxiety
por: Abend, Rany, et al.
Publicado: (2022)

OR16-2 Steroid Receptor Co-Activator Complexes Regulate Metabolic PFKFB Enzymes to Drive Therapy Resistant ER+ Breast Cancer
por: Benner, Elizabeth, et al.
Publicado: (2022)

Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity
por: Ibrahim, Ahmed, et al.
Publicado: (2019)

On the relation between anticipatory ocular torsion and anticipatory smooth pursuit
por: Rothwell, Austin C., et al.
Publicado: (2020)

Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones: A retrospective study of 93 patients
por: van der Heijden, L, et al.
Publicado: (2012)

Custom osteotomy guides for resection of a pelvic chondrosarcoma
por: Blakeney, William G, et al.
Publicado: (2014)

Giant Cell Tumor (GCT) of Capitate
por: Narayana Gowda, BS, et al.
Publicado: (2012)

Metastatic adenocarcinoma of Proximal Femur treated by Custom made Hip Prosthesis
por: Pal, Chandra Prakash, et al.
Publicado: (2012)

Surgery of non-spinal skeletal metastases in renal cell carcinoma
por: Ratasvuori, Maire, et al.
Publicado: (2016)

Osteochondroma Arising from the Thoracic Transverse Process
por: Wenyuan, Ding, et al.
Publicado: (2009)

Computer-assisted surgery in orthopedic oncology: Technique, indications, and a descriptive study of 130 cases
por: Gerbers, Jasper G, et al.
Publicado: (2014)

Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center
por: Dyrop, Heidi B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p4ie85tts1f7o9s5r7c4qieon8